Hostname: page-component-cb9f654ff-5jtmz Total loading time: 0 Render date: 2025-08-25T16:05:06.479Z Has data issue: false hasContentIssue false
  • English
  • Français

The Diagnostic use of the Amylobarbitone Interview Among Patients with Psychotic Illnesses

Published online by Cambridge University Press:  29 January 2018

Robert Woodruff
Robert Woodruff*
Affiliation:
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110
Get access Rights & Permissions [Opens in a new window]

Extract

Since 1932 the amylobarbitone (amobarbital sodium, Amytal) interview has been used as a technique for diagnostic evaluation of patients with psychiatric illnesses (Lindemann, 1932). Amytal has also been used to make mute patients talk, as a sedative, a mood elevator, and as an agent in various other types of psychiatric treatment such as sleep therapy, abreaction, narcoanalysis (Horsley, 1936), narcosynthesis (Grinker et al., 1945), narcosuggestion, and narcoplexis (Brickner et al., 1950).

Information

Type
Research Article
Information
The British Journal of Psychiatry , Volume 112 , Issue 488 , July 1966 , pp. 727 - 732
Copyright
Copyright © Royal College of Psychiatrists, 1966 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Ackner, B. Pampiglione, G. and Sainsbury, P. (1958). “Discussion on physiological measurements of ‘emotional tension’”. Proc. roy. Soc. Med., 51, 76–86.Google Scholar
Brickner, R. M. Porter, R. T. Homer, W. S. and Hicks, J. J. (1950). “Direct re-orientation of behaviour patterns in deep narcosis”. Arch. Neurol. Psychiat. (Chic.), 64, 165–195.Google Scholar
Eitinger, L. Laane, C. L. and Langfeldt, C. (1958). “The prognostic value of the clinical picture and the therapeutic value of physical treatment in schizophrenia and the schizophreniform states”. Acta psychiat. scand., 33, 35–53.CrossRefGoogle Scholar
Grinker, R. R. and Spiegel, J. P. (1945). War Neuroses. New York: Blakiston.Google Scholar
Hoch, P. H. (1947). “Narcodiagnosis and narcotherapy in the neuroses and psychoses”. N.Y. St. J. Med., 47, 2694–2698.Google Scholar
Hoch, P. H. (1946). “The present status of narco-diagnosis and therapy”. J. nerv. ment. Dis., 103, 248–259.Google Scholar
Horsley, J. S. (1936). “Narcoanalysis”. J. ment. Sci., 82, 416–422.Google Scholar
Kawi, A. A. (1960). “Electroencephalography and the sedation threshold (comparative studies on drug-induced phenomena)”. Dis. nerv. Syst., 21, 508–512.Google Scholar
Kraines, S. H. (1965). “Sodium amytal, hypnosis and psychotherapy”. Amer. J. Psychiat., 122, 458–460.CrossRefGoogle Scholar
Langfeldt, G. (1939). Schizophreniform States. Copenhagen: E. Munksgaard.Google Scholar
Lindemann, E. (1932). “Psychological changes in normal and abnormal individuals under the influence of sodium amytal”. Amer. J. Psychiat., 11, 1083–1091.Google Scholar
Lindemann, E. (1931). “The psychopathologcial effect of sodium amytal”. Biol. et Méd., 28, 864–866.Google Scholar
Shagass, C. Naiman, J. and Mihalik, J. (1956). “An objective test which differentiates between neurotic and psychotic depression”. Arch. Neurol. Psychiat. (Chic.), 75, 461–471.Google Scholar
Shagass, C. Naiman, J. (1955). “The sedation threshold, manifest anxiety, and some aspects of ego function.” 74, 397–406.Google ScholarPubMed
Shagass, C. Naiman, J. (1954). “A method of estimating tension in psychiatric patients”. Electroenceph. clin. Neurophysiol., 6, 221–233.Google Scholar
Stephens, J. H. and Astrup, C. (1963). “Prognosis in ‘process’ and ‘non-process’ schizophrenia”. Amer. J. Psychiat., 119, 945–952.Google Scholar
Valliant, G. E. (1964). “Prospective prediction of schizophrenic remission”. Arch. gen. Psychiat., 11, 509–518.CrossRefGoogle Scholar
Weinstein, E. A. Kamn, R. C. Sugarman, L. A. and Linn, L. (1953). “The diagnostic use of amobarbital sodium (‘Amytal Sodium’) in brain disease”. Amer. J. Psychiat., 109, 889–894.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.